A Study of Sirolimus for Injection (Albumin Bound) in Patients With Advanced Solid Tumors
Status:
Not yet recruiting
Trial end date:
2024-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to estimate the safety, tolerability, pharmacokinetics (PK), and
antitumor activity of Sirolimus for Injection (Albumin Bound) in patients with solid
malignancies.